STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 79 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q3 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $90,000 | -46.4% | 44,032 | -22.2% | 0.00% | – |
Q2 2021 | $168,000 | -1.2% | 56,585 | -8.1% | 0.00% | – |
Q1 2021 | $170,000 | +9.0% | 61,570 | -4.0% | 0.00% | – |
Q4 2020 | $156,000 | +30.0% | 64,148 | +12.1% | 0.00% | – |
Q3 2020 | $120,000 | -48.7% | 57,212 | -7.8% | 0.00% | – |
Q2 2020 | $234,000 | +12.5% | 62,022 | -43.8% | 0.00% | – |
Q1 2020 | $208,000 | -9.2% | 110,304 | +0.6% | 0.00% | – |
Q4 2019 | $229,000 | +94.1% | 109,599 | +122.4% | 0.00% | – |
Q3 2019 | $118,000 | +5.4% | 49,273 | +37.7% | 0.00% | – |
Q2 2019 | $112,000 | – | 35,793 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 5,376,039 | $47,309,000 | 51.34% |
Lyon Street Capital, LLC | 3,182,149 | $28,162,000 | 9.07% |
Opaleye Management Inc. | 1,590,000 | $14,071,000 | 4.02% |
Broadfin Capital, LLC | 2,793,752 | $24,725,000 | 3.85% |
Vivo Capital, LLC | 1,918,132 | $16,975,000 | 2.40% |
ARMISTICE CAPITAL, LLC | 3,372,000 | $29,842,000 | 2.28% |
PRECEPT MANAGEMENT LLC | 470,000 | $4,160,000 | 1.73% |
NEA Management Company, LLC | 4,141,308 | $36,651,000 | 1.63% |
Harvest Capital Strategies LLC | 825,000 | $7,301,000 | 1.14% |
Granite Point Capital Management, L.P. | 567,895 | $5,026,000 | 0.49% |